Connection

JAMES P ALLISON to Indoleamine-Pyrrole 2,3,-Dioxygenase

This is a "connection" page, showing publications JAMES P ALLISON has written about Indoleamine-Pyrrole 2,3,-Dioxygenase.
  1. Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4. J Exp Med. 2013 Jul 01; 210(7):1389-402.
    View in: PubMed
    Score: 0.423
  2. Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner. Cell Rep. 2015 Oct 13; 13(2):412-24.
    View in: PubMed
    Score: 0.124
  3. Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. Nat Med. 2011 Aug 28; 17(9):1094-100.
    View in: PubMed
    Score: 0.093
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.